Estradiol valerate

• Description :

  Estradiol valerate (β-Estradiol 17-valerate) is a synthetic estrogen widely used in combination with other steroid hormones in hormone replacement therapy agents.

• Product Name Alternative :

  β-Estradiol 17-valerate

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Estrogen Receptor/ERR

• Type :

  Reference compound

• Related Pathways :

  Vitamin D Related/Nuclear Receptor

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Endocrinology; Cancer

• Assay Protocol :

  https://www.medchemexpress.com/estradiol-valerate.html

• Concentration :

  10mM

• Purity :

  99.91

• Solubility :

  DMSO : ≥ 50 mg/mL|Ethanol : 12.5 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL

• Smiles :

  C[C@@]1([C@H]2OC(CCCC)=O)[C@](CC2)([H])[C@@](CCC3=C4C=CC(O)=C3)([H])[C@]4([H])CC1

• Molecular Formula :

  C23H32O3

• Molecular Weight :

  356.50

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Lei, B., et al., beta-estradiol 17-valerate affects embryonic development and sexual differentiation in Japanese medaka (Oryzias latipes) . Aquat Toxicol, 2013. 134-135: p. 128-34.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• CAS Number :

  [979-32-8]